State of New Jersey Common Pension Fund D’s Adamas Pharmaceuticals ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-93,500
Closed -$580K 1669
2019
Q2
$580K Hold
93,500
﹤0.01% 872
2019
Q1
$665K Hold
93,500
﹤0.01% 855
2018
Q4
$798K Hold
93,500
﹤0.01% 834
2018
Q3
$1.87M Hold
93,500
0.01% 759
2018
Q2
$2.42M Hold
93,500
0.01% 747
2018
Q1
$2.23M Hold
93,500
0.01% 750
2017
Q4
$3.17M Hold
93,500
0.01% 666
2017
Q3
$1.98M Hold
93,500
0.01% 743
2017
Q2
$1.64M Hold
93,500
0.01% 763
2017
Q1
$1.64M Hold
93,500
0.01% 767
2016
Q4
$1.58M Hold
93,500
0.01% 763
2016
Q3
$1.53M Hold
93,500
0.01% 773
2016
Q2
$1.42M Hold
93,500
0.01% 763
2016
Q1
$1.35M Hold
93,500
0.01% 768
2015
Q4
$2.65M Hold
93,500
0.01% 692
2015
Q3
$1.56M Hold
93,500
0.01% 782
2015
Q2
$2.45M Hold
93,500
0.01% 726
2015
Q1
$1.64M Hold
93,500
0.01% 791
2014
Q4
$1.62M Hold
93,500
0.01% 816
2014
Q3
$1.74M Hold
93,500
0.01% 760
2014
Q2
$1.71M Buy
+93,500
New +$1.68M 0.01% 761

Other funds holding ADMS

State of New Jersey Common Pension Fund D's ADMS Position: Q3 2019 in Review

State of New Jersey Common Pension Fund D sold out of Adamas Pharmaceuticals (ADMS) in Q3 2019, closing a stake of 93,500 shares — an estimated $580K sold.

State of New Jersey Common Pension Fund D first reported a position in ADMS in Q2 2014 and held it in 21 quarters. The position peaked at $3.17M in Q4 2017. 87 funds tracked by Wall St. Rank hold ADMS as of Q3 2019.

  • State of New Jersey Common Pension Fund D reported no remaining Adamas Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 93,500 Adamas Pharmaceuticals shares in Q3 2019, an estimated $580K.
  • State of New Jersey Common Pension Fund D first reported a position in Adamas Pharmaceuticals in Q2 2014 and held it in 21 quarters.
  • State of New Jersey Common Pension Fund D's Adamas Pharmaceuticals position peaked at $3.17M in Q4 2017.
  • 87 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q3 2019.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2019, filed 23 Oct 2019.